A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Clinical trial NCT01662882 · COMPLETED

Trial details

NCT number: NCT01662882
Sponsor: Avid Radiopharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease Mild Cognitive Impairment

Start date: 2012-10-01
Primary completion: 2013-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.